These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. "Diabodies": small bivalent and bispecific antibody fragments. Holliger P; Prospero T; Winter G Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6444-8. PubMed ID: 8341653 [TBL] [Abstract][Full Text] [Related]
5. Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3. Desplancq D; King DJ; Lawson AD; Mountain A Protein Eng; 1994 Aug; 7(8):1027-33. PubMed ID: 7809029 [TBL] [Abstract][Full Text] [Related]
6. Medical applications of single-chain antibodies. Huston JS; McCartney J; Tai MS; Mottola-Hartshorn C; Jin D; Warren F; Keck P; Oppermann H Int Rev Immunol; 1993; 10(2-3):195-217. PubMed ID: 8360586 [TBL] [Abstract][Full Text] [Related]
7. An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability. Whitlow M; Bell BA; Feng SL; Filpula D; Hardman KD; Hubert SL; Rollence ML; Wood JF; Schott ME; Milenic DE Protein Eng; 1993 Nov; 6(8):989-95. PubMed ID: 8309948 [TBL] [Abstract][Full Text] [Related]
8. Properties of bispecific single chain antibodies expressed in Escherichia coli. Kranz DM; Gruber M; Wilson ER J Hematother; 1995 Oct; 4(5):403-8. PubMed ID: 8581376 [TBL] [Abstract][Full Text] [Related]
9. Improving the productivity of single-chain Fv antibody against c-Met by rearranging the order of its variable domains. Kim YJ; Neelamegam R; Heo MA; Edwardraja S; Paik HJ; Lee SG J Microbiol Biotechnol; 2008 Jun; 18(6):1186-90. PubMed ID: 18600066 [TBL] [Abstract][Full Text] [Related]
10. Functional construction of the anti-mucin core protein (MUC1) antibody MUSE11 variable regions in a bacterial expression system. Asano R; Takemura S; Tsumoto K; Sakurai N; Teramae A; Ebara S; Katayose Y; Shinoda M; Suzuki M; Imai K; Matsuno S; Kudo T; Kumagai I J Biochem; 2000 Apr; 127(4):673-9. PubMed ID: 10739961 [TBL] [Abstract][Full Text] [Related]
11. Novel selection method for engineered antibodies using the mechanism of Fv fragment stabilization in the presence of antigen. Tsumoto K; Nishimiya Y; Kasai N; Ueda H; Nagamune T; Ogasahara K; Yutani K; Tokuhisa K; Matsushima M; Kumagai I Protein Eng; 1997 Nov; 10(11):1311-8. PubMed ID: 9514120 [TBL] [Abstract][Full Text] [Related]
12. Interaction of the octapeptide angiotensin II with a high-affinity single-chain Fv and with peptides derived from the antibody paratope. Cohen P; Laune D; Teulon I; Combes T; Pugnière M; Badouaille G; Granier C; Mani JC; Simon D J Immunol Methods; 2001 Aug; 254(1-2):147-60. PubMed ID: 11406160 [TBL] [Abstract][Full Text] [Related]
13. Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptides. McCartney JE; Tai MS; Hudziak RM; Adams GP; Weiner LM; Jin D; Stafford WF; Liu S; Bookman MA; Laminet AA Protein Eng; 1995 Mar; 8(3):301-14. PubMed ID: 7479692 [TBL] [Abstract][Full Text] [Related]
14. Cloning and expression of the variable regions of mouse myeloma protein MOPC315 in E. coli: recovery of active FV fragments. Cheadle C; Hook LE; Givol D; Ricca GA Mol Immunol; 1992 Jan; 29(1):21-30. PubMed ID: 1731188 [TBL] [Abstract][Full Text] [Related]
15. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain. Chen Y; Stollar BD J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006 [TBL] [Abstract][Full Text] [Related]
16. A form of anti-Tac(Fv) which is both single-chain and disulfide stabilized: comparison with its single-chain and disulfide-stabilized homologs. Rajagopal V; Pastan I; Kreitman RJ Protein Eng; 1997 Dec; 10(12):1453-9. PubMed ID: 9543007 [TBL] [Abstract][Full Text] [Related]
17. Comparative properties of the single chain antibody and Fv derivatives of mAb 4-4-20. Relationship between interdomain interactions and the high affinity for fluorescein ligand. Mallender WD; Carrero J; Voss EW J Biol Chem; 1996 Mar; 271(10):5338-46. PubMed ID: 8621386 [TBL] [Abstract][Full Text] [Related]
18. Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv. Reiter Y; Brinkmann U; Webber KO; Jung SH; Lee B; Pastan I Protein Eng; 1994 May; 7(5):697-704. PubMed ID: 8073039 [TBL] [Abstract][Full Text] [Related]
19. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain. Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666 [TBL] [Abstract][Full Text] [Related]
20. Effects of humanization and gene shuffling on immunogenicity and antigen binding of anti-TAG-72 single-chain Fvs. Pavlinkova G; Colcher D; Booth BJ; Goel A; Wittel UA; Batra SK Int J Cancer; 2001 Dec; 94(5):717-26. PubMed ID: 11745468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]